MOONLAKE IMMUNOTHERAPEUTICS (MLTX) Stock buybacks 2022–2024
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$50FY2024 · since FY2022: $0 → $50
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $50 | — |
| FY2023 | $0 | — |
| FY2022 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MLTX financial trends
MLTX RevenueMLTX Net incomeMLTX Net marginMLTX Gross profitMLTX Gross marginMLTX Operating incomeMLTX Operating marginMLTX Operating cash flowMLTX Free cash flowMLTX Capital expendituresMLTX Return on equityMLTX Dividends paidMLTX Total assetsMLTX Total liabilitiesMLTX Shareholders’ equityMLTX overview →